Jin Na, Pang Xin, Song Shiyang, Zheng Jin, Liu Zhimeng, Gu Tianxiang, Yu Yang
Department of Cardiac Surgery, The First Hospital of China Medical University, Shenyang, China.
Front Cardiovasc Med. 2024 Sep 18;11:1388577. doi: 10.3389/fcvm.2024.1388577. eCollection 2024.
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a critical support technique for cardiac surgery patients. This study compares the outcomes of femoral artery cannulation vs. combined femoral and axillary artery cannulation in post-cardiotomy VA-ECMO patients. This study aimed to compare the clinical outcomes of critically ill patients post-cardiac surgery under VA-ECMO support using different cannulation strategies. Specifically, the focus was on the impact of femoral artery (FA) cannulation vs. combined femoral artery and axillary artery (FA+AA) cannulation on patient outcomes.
Through a retrospective analysis, we compared 51 adult patients who underwent cardiac surgery and received VA-ECMO support based on the cannulation strategy employed-FA cannulation in 27 cases vs. FA+AA cannulation in 24 cases.
The FA+AA group showed significant advantages over the FA group in terms of the incidence of chronic renal failure (CRF) (37.50% vs. 14.81%, = 0.045), preoperative blood filtration requirement (37.50% vs. 11.11%, = 0.016), decreased platelet count (82.67 ± 44.95 vs. 147.33 ± 108.79, = 0.014), and elevated creatinine (Cr) levels (151.80 ± 60.73 vs. 110.26 ± 57.99, = 0.041), although the two groups had similar 30-day mortality rates (FA group 40.74%, FA+AA group 33.33%). These findings underscore that a combined approach may offer more effective hemodynamic support and better clinical outcomes when selecting an ECMO cannulation strategy.
Despite the FA+AA group patients presenting with more preoperative risk factors, this group has exhibited lower rates of complications and faster recovery during ECMO treatment. While there has been no significant difference in 30-day mortality rates between the two cannulation strategies, the FA+AA approach may be more effective in reducing complications and improving limb ischemia. These findings highlight the importance of individualized treatment strategies and meticulous monitoring in managing post-cardiac surgery ECMO patients.
静脉-动脉体外膜肺氧合(VA-ECMO)是心脏手术患者的一项关键支持技术。本研究比较了心脏术后接受VA-ECMO治疗的患者采用股动脉插管与股动脉联合腋动脉插管的结果。本研究旨在比较在VA-ECMO支持下,采用不同插管策略的心脏术后重症患者的临床结局。具体而言,重点是股动脉(FA)插管与股动脉联合腋动脉(FA+AA)插管对患者结局的影响。
通过回顾性分析,我们比较了51例接受心脏手术并根据插管策略接受VA-ECMO支持的成年患者——27例采用FA插管,24例采用FA+AA插管。
FA+AA组在慢性肾衰竭(CRF)发生率(37.50%对14.81%,P = 0.045)、术前血液滤过需求(37.50%对11.11%,P = 0.016)、血小板计数降低(82.67±44.95对147.33±108.79,P = 0.014)和肌酐(Cr)水平升高(151.80±60.73对110.26±57.99,P = 0.041)方面比FA组具有显著优势,尽管两组的30天死亡率相似(FA组40.74%,FA+AA组33.33%)。这些发现强调,在选择ECMO插管策略时,联合方法可能提供更有效的血流动力学支持和更好的临床结局。
尽管FA+AA组患者术前存在更多危险因素,但该组在ECMO治疗期间并发症发生率较低且恢复更快。虽然两种插管策略的30天死亡率没有显著差异,但FA+AA方法在减少并发症和改善肢体缺血方面可能更有效。这些发现突出了个体化治疗策略和精心监测在管理心脏术后ECMO患者中的重要性。